The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials.

Lyman, G H; Dale, D C; Culakova, E; Poniewierski, M S; Wolff, D A; Kuderer, N M; Huang, M; Crawford, J

Lyman, G H; Dale, D C; Culakova, E; Poniewierski, M S; Wolff, D A; Kuderer, N M; Huang, M; Crawford, J.

Afiliación

Lyman GH; Department of Medicine, Duke University, Durham. Electronic address: gary.lyman@duke.edu.
Dale DC; Department of Medicine, University of Washington, Seattle, USA.
Culakova E; Department of Medicine, Duke University, Durham.
Poniewierski MS; Department of Medicine, Duke University, Durham.
Wolff DA; Department of Medicine, Duke University, Durham.
Kuderer NM; Department of Medicine, Duke University, Durham.
Huang M; Department of Medicine, Duke University, Durham.
Crawford J; Department of Medicine, Duke University, Durham.

Ann Oncol ; 24(10): 2475-2484, 2013 Oct.

Article en En | MEDLINE | ID: mdl-23788754

Asunto(s)

Factor Estimulante de Colonias de Granulocitos/uso terapéutico; Neoplasias/tratamiento farmacológico; Neoplasias/mortalidad; Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Fiebre/tratamiento farmacológico; Humanos; Neutropenia/inducido químicamente; Neutropenia/tratamiento farmacológico; Ensayos Clínicos Controlados Aleatorios como Asunto; Resultado del Tratamiento

Palabras clave

granulocyte colony-stimulating factors; neutropenia; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor Estimulante de Colonias de Granulocitos / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2013 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google